Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US
Scientist/Sr. Scientist, Bio-analytical Chemistry
Dicerna Pharmaceuticals, Inc. - Watertown, MA
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US

More Jobs >>

Events

Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
Just Released: New Trends in Preventive and Therapeutic Vaccine
Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA

More Events >>

Related Tags >> DNA vaccine Scotland

Big DNA News

Most Popular Big DNA Story

Big DNA gains new backing to advance vax tech

November 6, 2008 — 8:50am ET | By John Carroll

An international consortium has invested £1.5 million in Scotland's Big DNA. The money is being used to advance the biotech company's technology using bacterial viruses to deliver vaccines. Read more...

Latest Headlines

Big DNA gains new backing to advance vax tech
November 6, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK